Yufang Medical has recently completed its Series A financing, led by Xingtai Capital, a Hefei government fund platform, and followed by old shareholder Huaying Investment, which is mainly used for the company's production capacity expansion, product development and so on. Founded in July 2017, the company is committed to independently developing a new generation of specialty CBCT imaging technology with versatile and affordable functions, and develops products mainly for different clinical applications of specialty CBCT system whole machine and related clinical software.
Youfang Medical's products feature 16*15cm non-spliced large field of view imaging and high precision imaging resolution of 28lp/cm. In addition, Arifang Pai CT realizes radiation dose reduction of about 75% through pulsed scanning technology + low-dose imaging algorithm.